Quick answer
Does 5-HTP help mood or sleep?
The evidence is not strong enough for a confident treatment claim. A Cochrane review found only two qualifying depression trials with 64 participants and judged the evidence inconclusive. A later meta-analysis still called for better placebo-controlled trials, and NCCIH says the effect of 5-HTP on insomnia has not been established. Because 5-HTP can raise serotonin, interaction screening matters more than choosing a dose from the internet.See reference 1,See reference 2,See reference 3,See reference 4
The essentials in ten points
- 5-HTP sits between tryptophan and serotonin in a biochemical pathway; a plausible pathway does not establish a clinical benefit.See reference 1,See reference 2,See reference 4
- The best-known controlled depression review included only two small trials and could not reach a reliable efficacy or safety conclusion.See reference 1
- A later synthesis reported a possible antidepressant signal but emphasized major limitations and the need for well-defined placebo-controlled trials.See reference 2
- NCCIH states that 5-HTP's effects on insomnia have not been established.See reference 3
- Evidence about tryptophan or melatonin should not be used as if it directly proves 5-HTP works.See reference 3
- No universal evidence-based dose is established for depression, anxiety or insomnia, and products may contain different ingredients or combinations.See reference 1,See reference 2,See reference 5
- Nausea, vomiting and diarrhea are common adverse effects; headache, insomnia and palpitations are also reported.See reference 1,See reference 4
- SSRIs, SNRIs, MAOIs, tricyclic antidepressants, linezolid and other serotonin-raising medicines create important interaction concern.See reference 4,See reference 5
- Carbidopa and some serotonin-raising supplements also require professional review before combination.See reference 4
- FDA does not preapprove dietary supplements for safety and effectiveness, so a product label is not evidence that a mood or sleep claim is proven.See reference 5
What the human evidence can support
- Claim
- Depression symptoms
- Best available evidence
- Two qualifying placebo-controlled trials with 64 participants in the Cochrane review; later studies remain heterogeneous
- Editorial conclusion
- Possible signal, but evidence is too small and weak for routine treatment advice.See reference 1,See reference 2
- Claim
- Insomnia or sleep quality
- Best available evidence
- NCCIH concluded that effects on insomnia had not been established
- Editorial conclusion
- Do not present 5-HTP as a proven sleep aid.See reference 3
- Claim
- Anxiety or stress
- Best available evidence
- No robust condition-specific trial base in the cited evidence
- Editorial conclusion
- A serotonin mechanism cannot fill the evidence gap.See reference 2,See reference 4
- Claim
- Appetite or weight loss
- Best available evidence
- Not established by the evidence base used for this guide
- Editorial conclusion
- Do not use 5-HTP as a self-directed weight treatment.See reference 2,See reference 5
- Claim
- A best daily dose
- Best available evidence
- Trials and products vary; the evidence base does not establish one universal regimen
- Editorial conclusion
- Dose selection cannot rescue uncertain efficacy or interaction risk.See reference 1,See reference 2,See reference 4
Why the serotonin pathway is easy to overread
The body converts tryptophan to 5-HTP and then to serotonin. Serotonin participates in many functions, and serotonin can be used to make melatonin. This explains why 5-HTP is studied; it does not show that swallowing more reliably improves a specific symptom.See reference 2,See reference 4
Clinical outcomes depend on absorption, metabolism, dose, product identity, baseline health, concurrent medicines and the condition being treated. A small change in a questionnaire is also not the same as remission, restored function or long-term safety.See reference 1,See reference 2
The safest conclusion is condition-specific: depression evidence is inconclusive, insomnia benefit is not established, and interaction screening is necessary before use.See reference 1,See reference 3,See reference 4
Interaction screening comes before any dose discussion
- Medicine or product
- SSRIs, SNRIs, MAOIs and tricyclic antidepressants
- Why it matters
- Adding another serotonin-raising product may increase adverse effects or toxicity risk
- Safe action
- Do not combine without the prescriber or pharmacist who knows the full regimen.See reference 4,See reference 5
- Medicine or product
- Linezolid has MAO-inhibiting activity
- Why it matters
- A case report describes serotonin syndrome with 5-HTP
- Safe action
- Avoid unsupervised combination and tell urgent-care clinicians about supplement use.See reference 4
- Medicine or product
- Carbidopa changes peripheral 5-HTP metabolism
- Why it matters
- A case report describes a scleroderma-like illness with the combination
- Safe action
- Use only under the treating specialist's direction.See reference 4
- Medicine or product
- St John's wort, SAM-e and other serotonin-focused products
- Why it matters
- Stacking products can make total exposure and attribution unclear
- Safe action
- Do not assume a supplement-supplement combination is safer than a medicine interaction.See reference 4,See reference 5
- Medicine or product
- 5-HIAA and selected neuroendocrine tests
- Why it matters
- 5-HTP can alter serotonin-metabolite results
- Safe action
- Tell the ordering laboratory and clinician before testing.See reference 4
Side effects and uncertainty
- Issue
- Nausea, vomiting or diarrhea
- What is reported
- Commonly reported and can be dose-limiting
- What to do
- Stop and seek advice if symptoms are severe or persistent; protect against dehydration.See reference 1,See reference 4
- Issue
- Headache, insomnia or palpitations
- What is reported
- Reported less commonly
- What to do
- Do not respond by adding more sleep or mood products.See reference 4
- Issue
- Agitation or mania-like change
- What is reported
- A case report exists with an MAOI combination
- What to do
- Stop use and obtain urgent clinical assessment for marked behavioral change.See reference 4
- Issue
- Ingredient identity and contaminants
- What is reported
- Supplements are not FDA-approved before marketing and past case reports involved product impurities
- What to do
- Choose transparent products, but do not treat a quality seal as efficacy proof.See reference 1,See reference 4,See reference 5
- Issue
- Long-term safety
- What is reported
- Not established by large, durable controlled trials
- What to do
- Reassess continued use rather than assuming that tolerated means proven safe.See reference 1,See reference 2
Who should pause before considering 5-HTP
People using any antidepressant, linezolid, carbidopa, tramadol or another medicine that affects serotonin should have a pharmacist or prescriber review the exact combination. A medication list must include supplements and combination products.See reference 4,See reference 5
Pregnant or breastfeeding people, children, and anyone planning surgery should ask their clinician or pharmacist before using 5-HTP. The evidence reviewed here does not establish a safe supplement regimen for these groups.See reference 3,See reference 5
Do not replace evidence-based depression, anxiety or insomnia care with 5-HTP, and do not taper a prescribed medicine in order to take it.See reference 1,See reference 3,See reference 5
Possible serotonin toxicity is an emergency
Stop the supplement and seek urgent medical care for a new combination of agitation or confusion, fever, heavy sweating, diarrhea, tremor, overactive reflexes, poor coordination, rapid or irregular heartbeat, seizure, or rapidly worsening symptoms, especially after combining 5-HTP with a medicine or supplement that affects serotonin. Bring the product and a complete medicine list. Do not try to manage a suspected interaction by adjusting doses at home.See reference 4,See reference 6
Frequently asked questions
Is 5-HTP a proven natural antidepressant?
No. Two small qualifying trials produced a possible signal, but the Cochrane review judged the evidence insufficient and later reviews still call for better trials.See reference 1,See reference 2
Does 5-HTP help insomnia?
It is not established. NCCIH specifically states that the effects of 5-HTP supplements on insomnia have not been established.See reference 3
What is the best 5-HTP dose?
The evidence does not establish one universal dose for mood or sleep. Interaction risk, product identity and the reason for use must be addressed before dose.See reference 1,See reference 2,See reference 4
Can I take 5-HTP with an SSRI?
Not without the treating prescriber or pharmacist. Both can affect serotonin and the combination may increase adverse-effect or toxicity risk.See reference 4,See reference 5
Is Griffonia seed extract the same as a measured 5-HTP ingredient?
A botanical extract can contain 5-HTP, but extract identity, standardization and other constituents can differ. Read the exact ingredient amount and do not assume trial results transfer to every product.See reference 4,See reference 5
References
- 1. Tryptophan and 5-hydroxytryptophan for depression
Cochrane Database of Systematic ReviewsSystematic review
- 2. Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis
Nutrition ReviewsMeta-analysis
- 3. Sleep Disorders and Complementary Health Approaches
National Center for Complementary and Integrative HealthOfficial guidance
- 4. 5-HTP
Memorial Sloan Kettering Cancer CenterEvidence review
- 5. FDA 101: Dietary Supplements
U.S. Food and Drug AdministrationOfficial guidance
- 6. Serotonin syndrome
MedlinePlus, U.S. National Library of MedicineOfficial guidance
Editorial transparency
- Published by
- LongevityMate Editorial Team
- Published
- Updated
Medical disclaimer
Educational information, not a diagnosis, mood or sleep treatment recommendation, or personal supplement plan. 5-HTP can interact with antidepressants, MAO-inhibiting medicines, linezolid, carbidopa and other serotonin-raising products and can affect laboratory tests. Do not start it, combine it, taper prescribed treatment or change psychiatric care without the treating clinician or pharmacist.